GOSR2 and epilepsy syndrome: We suspect that the complete clinical spectrum of BET1 variants will be more fully characterized with the identification of additional affected individuals, and similarly to GOSR2, the phenotype may be a spectrum, ranging from a predominant epilepsy syndrome at one end of the spectrum to an α‐DG‐related CMD with refractory epilepsy at the other, more severe end of the spectrum.